Eyeworld Daily News

EW SHOW DAILY 46 Saturday, April 26, 2014 Meeting Reporter T onight, an ophthalmic version of "The Tonight Show" will be staged, starring Terry Kim, MD, as the host and featuring special guests Steven Dell, MD, Keith Walter, MD, and Sonia Yoo, MD. This unique CME symposium will focus on reducing the impact of cataract surgical stress. The program will highlight recent advancements in therapy and surgical techniques that can help mitigate inflammation and reduce ultrasound energy. Here are a few of the topics that will be featured during this program: • Review the latest available anti- inflammatory therapies. • Learn more about the most recent femtosecond laser-assisted cataract surgery approvals. • Discuss which factors influence an increase in inflammation during routine cataract surgery. • Understand more about which comorbid conditions influence inflammation. • Hear how postop pain was the most significant predictor of patient dissatisfaction with their care. • Hear panel recommendations for the most appropriate pre- and postop inflammation treatment regimen. • Learn how an anti-inflammatory's formulation can affect the efficacy of the drug. • Review the similarities and differences between the available brand name and generic pharma- ceutical options. • Hear about an NSAID study that resulted in a low incidence of CME postop. • Understand techniques for a gentler surgery. • Review published literature on femtosecond laser impact on inflammation and ultrasound energy levels. Patient needs are changing. Cataract and especially refractive cataract patients are working, independent, using cell phones and computers and need good functional vision as quickly as possible. Therefore their expectations are high—they expect to see very clearly on day 1 and have no pain. The impact of postoperative in- flammation is a significant variable. During surgery physicians can employ techniques to decrease ultra- sound energy consumption as well as understand factors in the dosing, molecular design, and formulation of therapy that will impact the ability to mitigate and even prevent postoperative inflammation. For example, Dr. Walter uses the newly approved NSAIDs on every case and has had only one CME case in the last 1,300 cases. "The Tonight Show" format will incorporate the famous "Thank You Notes" segment as well as hashtags for trending topics to keep the pro- gram educational and entertaining. This program will involve the fol- lowing lectures and a related panel discussion on the reviewed topics. • Sonia H. Yoo, MD: "The True Impact of Ocular Inflammation on Refractive Cataract Surgery Outcomes" • Keith A. Walter, MD: "Maximiz- ing Penetration of Anti-Inflamma- tory Agents to Prevent Edema and Relieve Pain" • Steven J. Dell, MD: "Impact on Inflammation of Reducing or Eliminating Ultrasound Energy" Exciting data from the ASCRS Clinical Survey will be shared. The large membership survey com- pleted in April 2013 assessed clinical opinions and practice patterns from more than 1,000 unique responders. Most agreed inflammation has a significant impact on visual acuity and quality results (71%), visual recovery time (81%), and patient comfort and satisfaction (83%). This program will provide personal experiences and published results on how to mitigate the impact of inflammation in all of these areas. This CME symposium will take place in the Westin Boston Waterfront, Grand Ballroom today with a 5:00 p.m. registration and reception, and a 5:30 pm start time for the one-hour symposium. This program is supported by an unre- stricted grant from Bausch + Lomb. Onsite registration is available. EW "The Tonight Show" comes to ophthalmology by Beth Marsh Cataract surgery outcomes may not be meeting target standards. Understanding the inflammatory cascade to mitigate or eliminate postop pain and inflammation ASCRS Clinical Survey results: 91% of responders believe they will be doing laser cataract surgery in 10 years.

• Cover